SCHEMBL8401286

SCHEMBL8401286

CCC(=O)Nc1cc(OCc2ccccc2)cc2cccnc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC40A1 Q9NP59 2/20 0.51
KMT2A Q03164 6/20 0.50
MEN1 O00255 5/20 0.50
MAPT P10636 3/20 0.50
LMNA P02545 2/20 0.50
ALDH1A1 P00352 4/20 0.49
HDAC6 Q9UBN7 4/20 0.48
HTT P42858 1/20 0.47
HDAC1 Q13547 3/20 0.46
HDAC8 Q9BY41 1/20 0.46
EGFR P00533 1/20 0.45
ERBB2 P04626 1/20 0.45
ERBB4 Q15303 1/20 0.45
HPGD P15428 2/20 0.45
TSHR P16473 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
RAB9A P51151 1/20 0.45
POLB P06746 1/20 0.44
CYP3A4 P08684 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8401307 0.92 KMT2A (0.49) SLC40A1KMT2AMEN1MAPTLMNA
SCHEMBL8404193 0.90 KMT2A (0.47) SLC40A1KMT2AMEN1MAPTLMNA
SCHEMBL8401300 0.88 EGFR (0.49) SLC40A1KMT2AMEN1MAPTLMNA
SCHEMBL8110769 0.85 KMT2A (0.49) SLC40A1KMT2AMEN1MAPTLMNA
SCHEMBL8402851 0.84 KMT2A (0.68) SLC40A1KMT2AMEN1MAPTLMNA
SCHEMBL8103401 0.83 HDAC6 (0.57) KMT2AMEN1MAPTLMNAALDH1A1
Hydrochloric Acid SCHEMBL5323573 0.82 HDAC6 (0.56) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL17175758 0.79 HDAC6 (0.62) SLC40A1KMT2AMEN1MAPTALDH1A1
SCHEMBL5325195 0.79 HDAC6 (0.77) SLC40A1KMT2AMEN1ALDH1A1HDAC6
SCHEMBL5328199 0.79 HDAC6 (0.54) KMT2AMEN1MAPTALDH1A1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HAT1 SLC40A1 4650/4885KMT2A 37/4885MEN1 3832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.